Rice Hall James & Associates’s OmniAb OABI Stock Holding History
Bought
Maintained
Sold
Other funds holding OABI
WCM
CCM
VCM
PMG
TL
Rice Hall James & Associates's OABI Position: Q1 2026 in Review
Rice Hall James & Associates increased its OmniAb (OABI) stake by 6.1% in Q1 2026, buying an estimated $264K and bringing the position to 2,547,255 shares worth $4M. The position accounts for 0.22% of the portfolio, ranked #101.
Rice Hall James & Associates first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $16.7M in Q4 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.
- Rice Hall James & Associates held 2,547,255 shares of OmniAb worth $4M as of Q1 2026.
- Rice Hall James & Associates bought 146,167 OmniAb shares in Q1 2026, an estimated $264K.
- OmniAb made up 0.22% of Rice Hall James & Associates's portfolio in Q1 2026, its #101 holding.
- Rice Hall James & Associates first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
- Rice Hall James & Associates's OmniAb position peaked at $16.7M in Q4 2023.
- 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.
Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.